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Inflammatory reactions are believed to be triggered by innate signals and have a major
protective role by recruiting innate immunity cells, favoring lymphocyte activation and dif-
ferentiation, and thus contributing to the sequestration and elimination of the injurious
stimuli. Although certain lymphocyte types such as TH17 cells co-participate in inflam-
matory reactions, their generation from the naïve pool requires the pre-existence of an
inflammatory milieu. In this context, inflammation is always regarded as beginning with an
innate response that may be eventually perpetuated and amplified by certain lymphocyte
types. In contrast, we here show that even in sterile immunizations or in MyD88-deficient
mice, CD8 T cells produce a burst of pro-inflammatory cytokines and chemokines. These
functions follow opposite rules to the classic CD8 effector functions since they are gener-
ated prior to cell expansion and decline before antigen elimination. As few as 56 CD8+
inflammatory effector cells in a lymph node can mobilize 107 cells in 24 h, including
lymphocytes, natural killer cells, and several accessory cell types involved in inflamma-
tory reactions. Thus, although inflammation modulates cognate responses, CD8 cognate
responses also initiate local inflammatory reactions.
Keywords: CD8T cells, immune responses, effector functions, lymphocyte trapping, lymph-node shut-down-phase
INTRODUCTION
The main CD8 effector functions are believed to be the produc-
tion of IFN-γ and cytotoxic activity (CTL), which are induced after
extensive division. However, while studying CD8 T cell responses
at day 4 after priming we found that these cells had other prop-
erties. We named them “inflammatory effectors” because they
expressed abundant Tgfb, but none co-expressed TgfbR1 and R2,
indicating that TGF-β could only act in trans, where it is pro-
inflammatory [reviewed in Ref. (1)]. While testing their CTL activ-
ity (by co-injecting them with antigen-loaded and non-loaded
targets directly into the spleen), these effectors did not kill loaded
targets, but rather induced the local retention of both antigen-
loaded and non-loaded targets (2), mimicking the events described
in non-specific phase of lymphocyte trapping (3–5). Indeed, dur-
ing the first 2–4 days of an immune response all antigen-specific-
cells dispersed throughout the body are retained in the restricted
site where the antigen is first presented (a phenomenon named
lymphocyte trapping). Recent studies suggested that this local
retention was due to the formation of stable interactions between
antigen-specific T cells and the antigen-presenting cells (APCs).
These stable interactions would lead to T cell activation and
the subsequent down-regulation of the sphingosine-1-phosphate
(S1P) receptor S1P1 at the T cell surface, preventing antigen-
specific T cells to egress the lymphoid organ (6). It was also shown
that CD69 expression induced the down-regulation of S1P1 since
cells from CD69− mice failed to be retained (7, 8). However, these
events only explain why antigen-specific-cells remain in contact
with the APCs presenting the antigen. They do not explain how
all lymphocytes dispersed throughout the body are “screened” for
such binding capacity during a very short time-period after immu-
nization. This is particularly problematic since it was shown that
immediately after infection the number of APCs is very low: using
the dose L50 of influenza virus in aerosols only four infectious
particles were transmitted (9). In these circumstances, some cir-
culating antigen-specific-cells may fail to contact these rare APCs,
unless their transit time through the draining lymph node (DLNs)
is considerably modified.
Indeed, early studies on lymphocyte trapping revealed that
local recruitment of antigen-specific-cells was always preceded by
profound modifications of migration affecting all lymphocytes.
Elegant experiments in the sheep (3, 4) where the entry from the
blood and the traffic in afferent and efferent lymphatic vessels
were directly evaluated, as well as experiments in the mouse (5)
showed that shortly after antigen administration, the influx of both
antigen-specific and non-specific T cells into the DLN was much
increased (3, 5) whereas egress was totally blocked for 1–3 days
(3–5). This early reaction named “antigen non-specific trapping”
or “lymph-node shut-down-phase” was considered fundamental
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to allow every lymphocyte enough time to move among resident
cells until meeting the rare APCs first presenting the Ag. Early
studies proposed that such accumulation was due to an increase
in local blood flow (10), but other studies indicated that perfusion
rates were not modified: the apparent increase in blood flow was
only due to an increase in the size of the organ (11). Moreover,
an increase in the blood flow may explain the increase in lympho-
cyte input, but does not explain concomitant “shut-down-phase.”
Other studies reported that several inflammatory mediators could
modify cell egress. Interferons (12) and TNF were reported to have
these effects, but a detailed study of the effects of TNF injection
showed they did not mimic those induced by antigen (13).
We here describe that CD8 T cells express a burst of pro-
inflammatory cytokines immediately after cognate antigen stim-
ulation. These inflammatory effectors follow opposite rules to
classical CD8 functions, and are very potent effectors. They recruit
non-resident cells, 56 cells injected into a LN recruiting up to
107 cells in 24 h, including lymphocytes and multiple accessory
cell types involved in inflammatory reactions. They are generated
even in sterile immunizations. These results describe the charac-
teristics of a new CD8 effector differentiation phase. They show
that although local inflammation modulates T cell responses, CD8
cognate responses also initiate local inflammatory reactions.
MATERIALS AND METHODS
MICE AND IMMUNIZATION PROTOCOLS
C57BL/6 mice expressing the CD90.1 allotype marker (Ba mice)
and monoclonal (Mo) Rag2−/− mice expressing TCRαβ Tgs spe-
cific for the GP33 peptide of the LCMV (P14) or for the HY antigen
(HY) expressing different CD45 allotypes were obtained from our
breeding colonies at the Center for the Development of Advanced
Experimental Techniques, Orleans, France. CD3ε−/−CD45.1+
mice, and CD90.2+ Mo Rag2−/− mice expressing MoTCRαβ Tg
receptor specific for OVA peptides (OT1 or OT2) and MyD88-
deficient mice were gifts respectively from Antonio Freitas, and
from Mathew Albert and were bred at the Pasteur Institute’ animal
facilities. Listeria monocytogenesis (LM) (expressing both the OT1
and the OT2 OVA peptides: LM-OVA) or LM-GP33 were kind gifts
from L. Lefrançois – University of Connecticut Healthcare Center,
Farmington, CT. For immunization with LM, sex-matched 6–
8 weeks old CD90.1+ B6 mice were adoptively transferred with 106
lymph-node cells derived from either MoP14 Tg mice or MoOT-1
Tg mice. One day later, LM were recovered during the exponen-
tial growth phase, and mice were injected i.v. with 5000 CFU LM.
When specified in the text, naïve MoTg cells were labeled with
5µM CFSE (Molecular Probes, Eugene, OR, USA) prior to injec-
tion. GP33-specific endogenous cells were obtained from wild
type or MyD88-deficient mice immunized with the 5,000 CFU
LM-GP33. Under both these infection conditions, bacterial loads
(determined as CFU per liver or spleen) peaked at post-infection
days 2–3, and the response peak was by day 8–10 after infection
(not shown). For the generation of CD8 HY-specific effector cells,
6–8 weeks Rag2−/− female mice were injected i.v. with a mixture
of 106 female and 105 male bone marrow cells from CD3ε defi-
cient mice (14). Two days later these mice were injected i.v. with
0.5× 105 CD4+ (Marilyn) and CD8+ Mo TCR-Tg cells specific
for the male antigen.
ANTIBODIES USED FOR FLOW CYTOMETRY ANALYSIS AND CELL
SORTING
The following monoclonal antibodies (MoAbs) used for flow
cytometry and cell sorting were obtained from BD Pharmin-
gen (San Diego, CA, USA): anti-CD3, anti-CD4, anti-CD8 (53-
6.7), anti-CD8b (H35-172), anti-CD11b/Mac-1 (M1/70), anti-
CD11c, anti-CD19, anti-CD44 (1M781), anti-CD45.2 (104-2.1),
anti-CD69, anti-CD90.2/Thy1.2 (53-2-1), anti-DX5, anti-NK1.1
(PK136), anti-Ly6G/Gr1 (RB6-8C5), anti-Ly6c, anti-PDCA-1.
All the above-mentioned mAbs were directly coupled to FITC,
PE, PerCP, PECy7, allophycocyanin or Pacific Blue, or con-
jugated with biotin. Biotinylated mAbs were revealed with
streptavidin-allophycocyanin (BD Pharmingen, San Diego, USA),
or streptavidin-Pacific Orange (Molecular Probes, Eugene, USA).
Innate cell populations present in brachial lymph node (BRLN)
after the injection of naïve or effector cells were defined as fol-
lowing: NKs: DX5+ NK1.1+; cDCs: CD11chighPDCA-1−; pDC:
CD11clowPDCA-1+; monocytes: CD11bhigh LyC6high; granulo-
cytes (PMNs): CD11bhighLy6Clow. For the ex vivo detection of
cytokines and chemokines, mice were injected with 0.25 mg of
Brefeldin A (Sigma-Aldrich, St. Louis, USA) and intracellular
staining performed 6 h later (15), with the following Abs: rat
anti-mouse CCL3 (clone IC450A, R&D Systems, Minneapolis,
MN, USA); rat anti-mouse TNF-α (clone 557644, BD Pharmin-
gen, San Diego, CA, USA), rat anti-mouse CCL4 (clone MAB451,
R&D systems). Antibodies for phosphorylated signal transduc-
tion molecules and the respective isotype controls were purchased
from Cell Signaling Technology (Danvers, MA, USA): Akt (Ser473,
clone D9E)-PE, NF-kB p65 (Ser536, clone 93H1)-Alexa Fluor
488, p44/42 MAPK (Thr202/Tyr204, clone E10)-Alexa Fluor 488,
p38 MAPK (Thr180/Tyr182, clone 28B10)-Alexa Fluor 647 and
SAPK/JNK (Thr183/Tyr185, clone G9)–PE. Cells were analyzed on
a FACSCanto system and sorted on a FACS Aria system (Becton
Dickinson, Franklin Lakes, NJ, USA).
QUANTIFICATION OF ANTIGEN-SPECIFIC ENDOGENOUS CELLS
All the individual steps of this method are required to achieve
optimal recovery and quantification of naïve cells. Organs were
totally cleaned of fat and other adjoining tissues and distributed
in 24-well plates in RPMI medium supplemented with 2% fetal
calf serum and HEPES buffer. Cell suspensions were obtained by
mechanical disruption with forceps followed by digestion with
0.5 mg/ml collagenase type IV (Worthington Biochemical Cor-
poration, Lakewood, NJ, USA) and 5µg/ml deoxyribonuclease I
(Sigma-Aldrich, St. Louis, MN, USA) for 30 min at 37°C in 5%
CO2 with agitation. We found that this digestion step was critical,
since cell yields were much higher and the resulting cell suspen-
sions cleaner when compared with those obtained by mechanical
disruption alone.
For counting GP33-specific naïve cells, a known number of
LN Mo P14 Tg cells expressing different allotypes were added
directly to these suspensions prior to any further manipulation.
The cells were then washed and depleted of non-CD8 T cells
with a cocktail of MoAbs (TER119, CD19, Mac-1, GR1, CD4,
B220) and Dynabeads (Dynal AS, Oslo, Norway). All these Abs
were previously titrated to determine the binding efficiency and
the absence of non-specific binding/depletion. We found that
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this enrichment step was required to optimize the labeling and
discrimination of endogenous antigen-specific-cells. Cells were
labeled with PE- and APC-labeled multimers of MHC class I
loaded with GP33 peptide (Dextramers®, Immudex, Copenhagen,
Denmark) previously titrated on P14 Tg cells, and antigen-
specific-cells recovered by pull-down (16). In contrast to MHC
tetramers, these multimers associate a higher number of fluo-
rochrome and peptide-loaded MHC class I molecules, enabling
a better discrimination between antigen-specific and non-specific
endogenous cells. For counting antigen-specific-cells, the labeled
populations were diluted in 0.5–1 ml of FACS flow buffer and
acquired using the low-speed mode in a FACS-Canto. The use of
low-speed mode was also found important, since it reduced both
the cell loss during acquisition and the background non-specific
labeling.
CYTOKINE EXPRESSION. CORRELATIONS BETWEEN CELL
DIFFERENTIATION AND DIVISION “IN VIVO”
Assessment of the correlations between the expression of several
pro-inflammatory mediators and molecules involved in cytotoxi-
city with division in vivo was hindered by (i) the very low number
of cells present at each division at early time points of the response
and (ii) the small number of parameters than can be reliably used
with CFSE. In order to overcome these difficulties and study the
expression of several effector molecules simultaneously, we used
a single-cell multiplex RT-PCR technique previously developed
in our laboratory (17). This technique allows the simultaneous
detection of the expression of Tgfb1, Tnf, and cytotoxic genes
in each individual cell and we created compatible primers for
the simultaneously detection of chemokines (Figures S1 and S2
in Supplementary Material). Briefly, individual cells were sorted
and lysed and the mRNA reverse-transcribed by using specific 3′
primers for all genes. The 5′ primers are then added, and a first
15-cycle amplification step is initiated. The PCR products are then
split into different wells and a second, nested PCR is performed
for each gene separately. Given that the primers amplifying all the
mRNAs are present in the first PCR, the arrays have two major
requirements. Firstly, all PCRs should have the same efficiency, to
prevent preferential amplification. Secondly, neither the primers
nor the amplicons should compete during the first PCR reaction.
For new primers, validation of these two requirements are shown
in Figures S1 and S2 in Supplementary Material. Validation of the
other primers has been described previously (17).
The following primers were selected:
Xcl1: forward 5′-GAC-TTC-TCC-TCC-TGA-CTT-TC-3′, nested
forward 5′-GGA-CTG-AAG-TCC-TAG-AAG-AG-3′, and reverse
5′-TGC-CAT-CCA-CAG-TCT-TGA-TC-3′
Ccl3: forward 5′-AAG-GAT-ACA-AGC-AGC-AGC-GA-3′,nested
forward 5′-CCA-GTC-CCT-TTT-CTG-TTC-TG-3′, and reverse
5′-GAT-CTG-CCG-GTT-TCT-CTT-AG-3′
Ccl4: forward 5′-CCA-GCT-CTG-TGC-AAA-CCT-AA-3′,nested
forward 5′-GAG-CAA-CAC-CAT-GAA-GCT-CT-3′, and reverse
5′-GCT-CAG-TTC-AAC-TCC-AAG-TC-3′
28S: forward 5′-TAC-CGG-ACC-CTG-AAC-AGA-AT-3′, and
reverse 5′-GAT-GAT-CCT-CCG-GCA-TGT-TT-3′ (28S amplifi-
cation was used to test the plating efficiency).
We used two independent approaches to show that this method
can detect as few as two mRNA molecules per cell (17). NB: the
expression of all these effector molecules requires cognate antigen
stimulation. Naïve cells do not express these mRNAs. The infec-
tion milieu does not induce the expression of these mediators:
when mice are infected with LM that does not express OVA, OT-1
cells do not express these mediators.
Detection of cytokine proteins ex vivo was performed after
injection of Brefeldin A, as described (15).
THE INFLAMMATORY CAPACITY OF CD8 T CELLS IN VIVO
Sorted naïve or effector CD90.2 Tg T cells obtained from the spleen
2.5 days after immunization. In some experiments they were mixed
at 4°C with 50% “High Concentration” Growth factor-reduced
Matrigel (BD Biosciences, San Jose, USA), and injected subcuta-
neously in the ear of CD90.1 recipient mice. In other experiments,
the BRLN was accessed by a small vertical skin incision parallel
to medial border of the scapula in anesthetized mice. The same
cells were injected directly in the BRLN in a 10µl volume using an
insulin syringe, and the skin incision was closed with one wound
clip. We aimed to inject 60 or 600 cells/mouse but variations in
cell numbers were to be expected after such high dilutions and
injection. To determine the actual number of cells present in the
BRLN after injection, we counted them in the final cell suspension
and in the BRLN of control mice shortly after injection.
To determine the best time point for studying the effect of these
effectors, we measured the weight of LNs at different times after
injection of effector T cells. For evaluation of S1P, LNs were stud-
ied 16 h after the injection of effectors, since their weight had not
yet increased at that time point. For the detection of cell accu-
mulation, LNs were studied between 24 and 30 h post-injection,
when they had already increased in size. For the detection of S1P,
we used the S1P bioassay described previously (18) with WEHI231
cells expressing Flag-S1P1 (a kind gift of J. Cyster). This method
was slightly modified to increase sensitivity. To concentrate the S1P
amounts recovered from the LN, we extracted S1P in a 50µl vol-
ume, and reduced the reaction volumes to 40µl and the number
of WEHI231 cells to 2× 104/well. To reduce background labeling
(variations of Flag-S1P1 expression in WEHI231 cells incubated
with medium alone) these cells were previously sorted to obtain
homogeneous populations expressing the same level of Flag-S1P1.
RESULTS
CD8+ INFLAMMATORY EFFECTOR T CELLS DO NOT FOLLOW THE RULES
THOUGHT TO GOVERN CD8+ DIFFERENTIATION INTO EFFECTOR CELLS
Since in the first 1–4 days after antigen administration cell input
to the DLN is much increased, we studied if CD8 T cells would
express mediators justifying this increase. When Mo TCR-Tg
cells were stimulated with LM expressing the OT1 and the OT2
epitopes, CD8 OT1, but not the CD4 OT2 cells abundantly
expressed a panoply of chemokines – Xcl1, Ccl3, and Ccl4 by day
2 after immunization, while this expression was lost before the
immune response peak (Figure 1A). OT1 cells also expressed Tnf
(Figure 1A), reported to increase HEV permeability and reduce
LN egress (19). Ex vivo detection of protein in Brefeldin A injected
mice confirmed that secretion of pro-inflammatory mediators
was restricted to the early response (Figure 1B). Production of
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FIGURE 1 | Expression of inflammatory mediators by CD8T cells.
(A,B) Mo CD90.2 TCR-Tg cells were transferred to CD90.1 B6 mice, and
immunized with LM-OVA expressing the OT1 and OT2 epitopes. At
different time points after infection we determined: (A) The proportion of
OT1 and OT2 Tg cells expressing these mRNAs evaluated in 72 individual
cells by single-cell RT-PCRs. (B) The ex vivo intracellular expression of
pro-inflammatory proteins in Brefeldin A injected mice. Barriers to identify
positive cells were based on the labeling of the same cell suspension with
isotype control antibodies. The lack of suitable Abs prevented us from
evaluating XCL1 expression. (C) Mo CD90.2 P14 TCR-Tg cells were
transferred to CD90.1 B6 mice. 24 h later, these transferred mice, as well as
My88+ and MyD88− mice were immunized simultaneously with LM-GP33.
(Continued)
FIGURE 1 | Continued
CD8+ CD69+ GP33-specific-cells were sorted from these three mice types
at days 2 and 3 after priming. For that purpose, spleen cell suspensions
were depleted of non-CD8 T cells. The P14 Tg cells were identified by their
co-expression of CD90.2 and CD8β. Endogenous cells from MyD88+ and
MyD88 B6− mice were identified by triple co-expression of CD8β, and APC,
and PE labeled GP33-Dext. Results show the levels of these mRNAs in
CD69+ GP33-specific-cells 2 (upper graphs) and 3 days (lower graphs) after
immunization, evaluated by qRT-PCR.
these mediators was dependent on the recognition of the Ag by
antigen-specific-cells. When these mice were injected with LM
not expressing OVA, OT-1 cells did not express any effector func-
tion. Mo CD8 anti-HY TCR-Tg cells but not Mo CD4 anti-HY
Marilyn TCR-Tg immunized with male cells also produced a sim-
ilar cytokine/chemokine burst, although Ccl3 and Ccl4 levels were
lower than found in OT1 CD8 cells (not shown).
Since the above results were obtained with TCR-Tg cells we
wished to evaluate if endogenous cells shared the same properties.
Moreover, since immunization with male cells does not involve
obvious innate signals we wished to study the impact of such sig-
naling in inflammatory effector functions. We compared by qRT-
PCR the expression of the mRNAs coding for these mediators by
different types of CD69+ GP33-specific CD8 T cells, immunized
with LM-GP33. We found equivalent expression in TCR-Tg cells
from P14 mice and in endogenous cells from MyD88+ or MyD88−
B6 mice (Figure 1C). These results show that endogenous and
TCR-Tg cells share the same properties. Moreover, such properties
are not affected by the abrogation of the MyD88 pathway.
The kinetics of expression of these mediators was surprising,
since it is generally believed that all CD8 effector functions increase
with cell division, and decline when antigen is eliminated (20,
21). Correlation of cell division with differentiation (Figure 2A)
confirmed that the expression of cytolyic effector molecules does
follow these rules: they increase with division (lower panel), and
we previous confirmed that they decline only after antigen elim-
ination (2). In contrast, inflammatory mRNAs were expressed in
CD69+ cells before any division, declining with division. While
effector functions are believed to decline only when antigen is
eliminated, inflammatory effectors also contradicted this rule, as
they were lost by day 4 after immunization (Figure 2A), when we
previously showed that antigen concentrations were still (2).
We next wished to determine the cause for this early decline.
Given that the expression of these mediators requires MAPK
activation, we looked at whether such activation could be inter-
rupted during the early phases of the CD8 response. Indeed, both
OT-1 TCR-Tg cells and endogenous cells down-regulated their
TCR (Figures 2B,C) and CD3ε (not shown) losing the ability to
bind peptide-loaded dextramers (Dext: MHC multimers with a
higher number peptide – MHC complexes than tetramers). The
MAPK activation declined progressively and was fully abrogated
before the immune response peak (Figure 3), restricting CD8s’
inflammatory profile to the first days after priming.
Overall, these results demonstrate that the classic description of
the sequential steps of CD8 responses (activation, expansion, dif-
ferentiation into effector functions, antigen elimination, effector
function loss) must be revised. CD8 T cells actually undergo two
Frontiers in Immunology | T Cell Biology December 2013 | Volume 4 | Article 452 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sung et al. CD8 inflammatory effectors
FIGURE 2 | (A) Correlation between CD8 division and differentiation.
(A) CFSE-labeled Mo CD90.2 OT-1 Tg cells were transferred to CD90.1
B6 mice and studied at different time points after infection with
LM-OVA. Left: CFSE dilution and the gates used to sort individual cells
at each division. Right: expression frequency, as evaluated in RT-PCRs in
96 individual cells. (B,C) TCR expression after immunization with
LM-GP33. (B) TCR-Tg cells. 5,000 Mo CD90.2+ P14 TCR-Tg cells were
injected into CD90.1+ B6 mice prior to infection. Results show
APC-Dext-GP33 binding in CD90.2+ CD8+ Tg T cells in naïve (upper
graph) and infected mice, at different days (D) after immunization.
(C) Endogenous cells. CD90.1 B6 mice were immunized with LM-GP33.
Results show Dext-GP33 PE and APC double-labeling in gated CD8
spleen cells in naïve mice (upper graph) and primed mice at different
days (D) after infection.
independent differentiation phases, governed by opposite rules.
Immediately after activation they differentiate into inflammatory
effectors, but then lose their pro-inflammatory properties as they
divide and gradually differentiate into CTLs.
THE PHYSIOLOGIC ROLE OF CD8+ INFLAMMATORY EFFECTOR T CELLS:
I. QUANTIFICATION OF THEIR NUMBER
Since the generation of inflammatory effectors is restricted to the
first three-four divisions, their number should never exceed that of
naïve cells by more than a factor of eight. It is difficult to envisage
that such low effector number has any major role in the immune
response, since the number of naïve cells for a single GP33 epitope
was described to average 200 cells/mouse (16). However, this num-
ber is known to be an underestimate (16). Indeed, from the 50 LN
reported to be present in the mouse, only nine were included in
this calculation. The identification of the naïve cells after tetramer
pull-down was not controlled for the efficiency of tetramer binding
nor for losses during purification.
We revised these estimates by treating individual organs with
collagenase/DNase (increasing substantially total cell recovery),
and adding a known number of antigen-specific “reference pop-
ulations” (RP) to these cell suspensions. These RP bind the same
tetramers as endogenous cells and therefore can be used as con-
trols for the efficiency of tetramer binding. Since they undergo the
same purification steps, their recovery rate can be used to control
non-specific cell losses during purification. We also used the more
efficient Dext instead of tetramers for the purification of antigen-
specific-cells. Using these combined approaches, we evaluated the
total number of naïve cells for the LCMV response. This evalua-
tion can only be determined for this response, since this calculation
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FIGURE 3 |TCR signaling transduction at different time points after
immunization. Mo CD90.2+CD45.1+ OT-1 TCR-Tg cells were transferred into
CD90.1+ CD45.2+ B6 hosts and infected with LM-OVA. The figure shows the
expression of phosphorylated signal transduction molecules in CD90.2+
CD45.1+ CD8+ Tg cells at different time points after priming. The labeling with
isotype controls is shown in gray.
requires the identification of all antigen epitopes and their relative
representation in the response. These data are only available for
the LCMV response, where it is known that the GP33 specificity
corresponds to 10% of the LCMV specific-cells (22).
When two RP of monoclonal P14 TCR-Tg LN T cells (104
CD90.2 CD45.1 and 103 CD90.2 CD45.2 P14 cells) were added
to BRLN of CD90.1 CD45.2 mice, endogenous CD90.1 CD8 T
cells could be easily differentiated from CD90.2 RP populations
(Figure 4A: left). Both RP (CD45.1 and CD45.2) were fully labeled
with GP33-Dext, demonstrating that Dext binding of the suspen-
sion was efficient (not shown). Moreover, CD45.2 and CD45.1
RP populations maintained the same relative representation after
purification (10:1) demonstrating that less abundant cells were not
preferentially lost (Figure 4A, middle). Within CD90.1+ endoge-
nous CD8 T cells, Dext+ cells were clearly visualized (Figure 4A,
right), the number of GP33-specific-cells in the BRLN averag-
ing 60. Similar results were obtained for the number of epitope
HY-specific or SIINFEKL – OVA specific naïve CD8+ cells.
To calculate the number of naïve cells/mouse identical studies
were performed in the spleen and in 39 other LN. In the three inde-
pendent experiments we performed we found about 3,800 naïve
GP33-specific-cells (Figure 4B). Since the GP33 specificity corre-
sponds to 10% of the LCMV response (22), total number of naïve
cells responding to LCMV should be about 3.8× 104, and the total
number of inflammatory effectors could reach 3.04× 105. It must
be noted that this number is still an underestimate, since we only
managed to recover 39 LN of the 50 LN described, and naïve cells
present in the blood and bone marrow were not counted. How-
ever, it is likely that the number of naïve cells would not be much
higher since the LN we did not harvest were described as relatively
small, and the BM harbors mostly antigen-experienced cells.
THE PHYSIOLOGIC ROLE OF CD8+ INFLAMMATORY EFFECTOR T CELLS:
II. CHEMOKINES CAN ATTRACT CELLS AT DISTANCE
A role of the chemokine burst produced by CD8 T cells in the
increase in cell input during antigen-non-specific trapping would
imply that these chemokines should create a gradient able to
recruit cells located out-side the DNL. However, it is yet unclear
if chemokines only modify the migration of resident cells (23). To
test if CD8 inflammatory effectors attract cells at distance, they
should be isolated from the in vivo inflammatory milieu, trans-
ferred to a normal mouse and retained in a particular site where
non-resident cells would not migrate, and their effect studied at
distance. We found that this was possible when sorted effectors
were immobilized subcutaneously in the ear with the collagen-
laminin matrix Matrigel. Matrigel is liquid at 4°C but solidifies
after injection, and is frequently used to promote viability of tumor
cell lines injected subcutaneously. When injected with Matrigel,
effectors remained viable and at the injection site and could be
recovered and from the Matrigel plug, but were absent in the
auricular LN (ALN) (Figure 5A) and other organs (not shown)
24 h later. When 5× 104 naïve OT-1 were immobilized in the ear,
naïve cells did not modified the number or cellular composition
of the ALN as compared to non-injected mice (not shown). In
contrast, when similar numbers of OT1 inflammatory effectors
were retained, the ALN increased in size, accumulating both T
and B lymphocytes (Figure 5B). We also observed a preferential
accumulation of NK cells, CD11b+Ly6Chi inflammatory mono-
cytes, cDCs, and CD11b+Ly6Clow PMNs (Figures 5B,C) reflecting
the production of MIP-1 and XCL1 chemokines by these CD8
T cells. Similar effects were observed when the effector number
was reduced 20-fold. These results show that CD8 inflammatory
effectors are able to recruit non-resident cells.
When immobilized in the ear, HY naïve cells had no effect,
while HY-specific inflammatory effectors induced a major accu-
mulation of XCR1 expressing cells (24, 25): T and B lymphocytes,
NK cells, and CD11b+Ly6Chi inflammatory monocytes. Indeed,
upon injection of HY effectors the ALN could triple in size, i.e.,
LN hypertrophy was more marked than that found after injec-
tion of OT-1 effectors. Accordingly to their lower expression of
MIP-1 chemokines, DCs and PMNs that are recruited by MIP-
1 chemokines (26, 27), were less affected (Figure 6). Thus, CD8
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FIGURE 4 | Quantification of the naïveT cell pool. (A) Quantification of
antigen-specific naïve cells in the BRLN. Reference populations (RPs: 104
CD90.2 CD45.1 cells and 103 CD90.2 CD45.2 P14 cells) were added to
collagenase/DNase digests of the BRLN from CD90.1 B6 mice. Cell
suspensions were depleted of non-CD8 T cells, and antigen-specific-cells
purified by Dext pull-down. Left: the gates used to identify CD90.2+ RP and
CD90.1 endogenous cells. Middle: CD45 allotypes distribution in RPs. Right:
GP33-Dext labeling in CD90.1 endogenous CD8 T cells. (B) Estimation of the
size of the naïve GP33-specific T cell pool. Results show the number of
Dext-GP33-specific-cells recovered/mouse in three independent experiments.
inflammatory effectors generated after a sterile immunization are
also able to recruit non-resident cells at distance.
THE PHYSIOLOGIC ROLE OF CD8+ INFLAMMATORY EFFECTOR T CELLS:
III-LOCAL MODIFICATIONS AFTER INTRA-NODAL INJECTION OF
PHYSIOLOGIC NUMBERS
Since at the beginning of a natural infection the inflammatory
effectors should only be the rare resident cells already present in a
lymphoid organ, we aimed to study the role of such effector num-
bers after intra-nodal injection. We first selected the target LN used
for injection, which should be relative large (facilitating calcula-
tion of the number of naïve resident cells) and giving easy access to
injection. We studied the positions and sizes of several superficial
LNs and the best procedure to access them and found the BRLN
suitable in both respects. After collagen and DNase digestion it
harbors 5–8× 106 cells. It can be reproducibly accessed through
a very small skin incision near the scapula. Since in this node
the number of naïve cells specific for the GP33 epitope averages
60 cells (Figure 4A), the number of naïve LCMV specific-cells
should be 600, since the GP33 specificity corresponds to 10%
of the LCMV response (22). Therefore the total number of res-
ident effectors should be lower than 4,800. Remarkably, even a
much lower number of OT-1 (Figure 7A) or anti-HY inflamma-
tory effectors (Figure 7B) injected directly in the BRLN induced a
major local recruitment. Again, the type of recruited cells reflected
the chemokine profile expressed by each effector type.
We were surprised that as few as 56 effectors could attract up to
107 cells to a LN in 24 h (Figure 7B), and wondered whether other
mediators could be involved. Given that (i) LN egress is totally
blocked during early trapping (3, 4) and (ii) S1P gradients con-
trol this egress (18), we hypothesized that inflammatory effectors
could increase local S1P concentrations and thus contribute to the
local retention. Indeed, since inflammatory mediators induce the
release of S1P by certain resident cell lines in vitro (28, 29), it was
hypothesized that local inflammation could induce S1P release by
tissue-resident cells and thus contribute to cell accumulation at
the inflammatory site (30). This attractive hypothesis could not be
confirmed experimentally since previous methods did not allow
S1P measurements in small tissue fragments. We modified these
methods to increase sensitivity and found that intra-nodal injec-
tion of inflammatory effectors induced the up-regulation of S1P
in tissue extracts from that BRLN 16 h later (Figure 7C). By com-
parison with a known concentration of standard, synthetic S1P,
the amounts of S1P recovered from BRLNs injected with effectors
ranged from 1422 ng/g to about 2800 ng/g, i.e., 2.4- to 5-fold higher
than the value reported after direct extraction of S1P from a large
LN pool (18). This value is likely an underestimate, since the S1P
levels in BRLNs injected with 56 effectors were 10-fold higher than
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FIGURE 5 | Inflammatory effector CD8T cells recruit non-resident
cells. Sorted Mo CD90.2+ OT-1 naïve cells or inflammatory effectors
(recovered 2.5 days after LM-OVA infection) were injected with matrigel
subcutaneously in the ear of CD90.1+ mice. (A) Recovery of injected cells
from the matrigel plug (left) and the auricular LN (ALN) (right) 24 h after
injection. (B,C) Cell populations recovered in the ALN of injected mice,
24 h after injection. (B) Results show cell numbers and are mean±SEM of
three independent experiments. (C) Results show the gates used to
identify different cell types and are from one representative experiment
out of the three we performed.
in BRLNs injected with a 600 naïve cells, studied simultaneously
(Figure 7C). Since a twofold increase in the S1P concentrations is
enough to induce major changes in lymphocyte egress (6) the S1P
amounts detected here justify the blockage of LN egress.
DISCUSSION
Our present results characterize an important function of CD8
T cells, which modifies the actual paradigms on: (i) when CD8
cells acquire and lose effector functions; (ii) the roles that CD8
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FIGURE 6 | CD8+ inflammatory effectorT cells generated in sterile
immunizations also recruit non-resident cells. Sorted Mo CD90.2+
HY-specific CD8 naïve cells or inflammatory effectors (recovered at
2.5 days after immunization with male cells) were injected with
matrigel subcutaneously in the ear of CD90.1+ mice. (A) Results
show the number of different cell types recovered in the ALN of
injected mice, 24 h after injection and are the mean±SEM of three
independent experiments. Cell populations were identified as
described in Figure 5. (B) Major accumulation of inflammatory
monocytes in the ALN of mice injected with inflammatory effectors.
Results are from one representative experiment, out of the three
performed.
cells have in immune responses; and (iii) how inflammation and
cognate immune responses interact.
It is generally believed that after antigen stimulation CD8 T
cells effector functions increase with division and decline once the
antigen is eliminated. Our results allow comparing the differen-
tiation into killer or inflammatory functions by the same CD8
population throughout divisions/throughout time. While cyto-
toxicity follows the “classic” rules of CD8 differentiation, opposite
rules govern CD8 inflammatory functions. These are induced
before division, decrease while cells divide and decline at the
time point of the response when we previously showed antigen
concentrations to be quite high (2). The shortness of this inflam-
matory burst is likely due to extensive TCR down-regulation,
which abrogates MAPK activation preventing the expression of
these mediators.
The loss of TCR surface expression after in vitro T cell acti-
vation is well documented, but it was shown to reverse by 24 h
(31). Down-regulation of the TCR was also reported after in vivo
immunization (32, 33). However, we were now able to quan-
tify this phenomenon. By visualizing Mo TCR-Tg cells recogniz-
able by a different allotype, present in frequencies equivalent to
those of endogenous antigen-specific-cells, we found that 80%
lost their TCR expression by day two after priming. Moreover,
this down-regulation persisted for several days: by day 4 after
immunization 50% of the responding cells yet fail to express
the TCR. Comparison of Dext labeling in naïve and primed
endogenous cells also shows considerable down-regulation during
these time points. These results identify a major limitation to the
study of endogenous CD8 responses. They show that the majority
of endogenous antigen-specific-cells cannot be identified during
early responses.
While it is generally believed that the major CD8 effector func-
tions are γ-IFN production and cytotoxicity, we now describe in
detail a new CD8 effector phase: the secretion of a major burst
of pro-inflammatory mediators shortly after activation which
directly or indirectly promote the recruitment of lymphocytes
and accessory cells types to the location where antigen is present.
These cells are likely involved in the “antigen non-specific/shut-
down-phase” of lymphocyte trapping-a process proposed to have
a fundamental role in allowing rare APCs at a restricted loca-
tion to screen the total lymphocyte pool in 24–48 h, in order
that all antigen-specific-cells dispersed throughout the body may
be selected for APC binding. Elegant experiments performed 4–
5 decades ago identified a major increase in cell input shortly
after antigen stimulation, and a total block in cell egress, which
retained both antigen-specific and non-specific T cells at the loca-
tion where antigen is first presented (3–5). It was proposed that
these modifications were induced by an increase in blood flow
(10), but our previous measures of blood flow during trapping
indicated that the reported increases were due to an increase in
organ size. Indeed, when the blood flow was related to the organ
weight, perfusion rates were not modified (11). In contrast, our
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FIGURE 7 | Effects of intra-nodal injection of physiologic numbers of
CD8+ inflammatory effectorT cells. (A,B) The indicated number of sorted
CD90.2+ naïve or inflammatory effectors (recovered 2.5 days after priming)
were injected into the BRLN of CD90.1+ B6 mice. The BRLNs were
removed 24 h later and the different cell types identified as shown in
Figure 5. Results compare cell recovery in mice injected with naïve CD8+
T cells or inflammatory effector CD8+ T cells (A) Mice were injected with
OT-1 Tg cells. (B) Mice injected with HY Tg cells. Similar results were
obtained after injection of P14 Tg cells. (C) The BRLNs were injected with
500 naïve cells, 80 OT-1 effectors or 56 HY effectors. Results show of S1P
amounts in LN lysates 16 h later, compared with known amounts of a
synthetic S1P. Gray bars represent the Flag-S1P1 expression of WEHI231
incubated with medium alone. Results are representative of the seven
experiments we performed.
results implicate the chemokine burst produced by inflamma-
tory effectors in this recruitment. This burst is able to mobilize
non-resident cells. Importantly, the cell types recruited either at
distance or after the intra-nodal injection of inflammatory effec-
tors correlate with the chemokine profile of effector cells: HY
effectors which express mainly XCL1 recruiting predominantly
inflammatory monocytes and lymphocytes, while OT-1 effectors
secreting CCL2 and CCL3 also promoting DC and granulocyte
recruitment. Inflammatory effectors also secrete TNF, known to
participate in DC and T cell recruitment besides having other
functions in DC stimulation, T cell co-stimulation and survival
[review in Ref. (19)].
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When we first detected these early effector functions we were
unconvinced that they would have any relevant role in immune
responses, since the number of these effectors should be very low.
Surprising, they are very potent effectors since 56 present in a LN
harboring 5–8× 106 cells are able to recruit up to 107 cells in 24 h.
It must be noted that the different cell types recruited to the DLN
may co-participate in this recruitment, since they are also able to
secrete these mediators. In particular, injection of antigen-loaded
DCs was shown to increase LN cellularity, which was potentiated
by co-injection of TNF (34). However, it was not established if
this effect was direct, or mediated by the recruited antigen-specific
T cells. In spite of the possible contribution of other cell types,
the time course of cell recruitment and LN “shut-down” phase
overlaps that of the CD8 inflammatory burst, indicating that the
latter has a fundamental role in the overall regulation of these
phenomena.
Besides secreting inflammatory mediators, the intra-nodal
injection of very low effector numbers also induced a 10-fold
increase in S1P recovery from the injected LN, as compared to
LN injected with eightfold more naïve cells. S1P up-regulation
precedes LN hyperplasia, since it is already detected at 16 h after
effector injection, and thus may also contribute to the local cell
accumulation by immobilizing recruited cells. The kinetics of S1P
up-regulation also mimics the CD8 inflammatory burst, since it
is stable at 24 h and declines by days 2–3 after effector injec-
tion (data not shown). It must be noted that we studied both
intracellular and secreted S1P, since it is not possible to dis-
criminate soluble S1P from tissue samples (J. Pereira, personal
communication). However, it is likely that part of this S1P is
secreted, being involved in the LN “shut-down” phase of lym-
phocyte trapping, since (i) a twofold increase in secreted S1P was
found sufficient to modify lymphocyte migration (6); and (ii) the
injection of FTY720 (which is rapidly phosphorylated in vivo gen-
erating an SIP analog) mimics the DLN shut-down-phase (23).
Part of the S1P may also be intracellular, where it was shown to
have important functions, by co-participating in TNF signaling,
activating NF-Kb, and contributing to the anti-apoptotic role of
TNF (35).
Concerning the production of S1P, we confirmed that T cells
do not secrete it (23). We failed to detect this molecule in super-
natants of activated T cells in vitro. Quantitative evaluation of
Sphk1 and Sphk2 showed equivalent ex vivo expression levels in
naïve and inflammatory effectors. The S1P recovery was similar
in LN injected with 56 or 1,000 effectors (not shown). There-
fore, as described in all the systems studied so far, tissue-resident
cells likely produced this mediator (23). In contrast, our data
does not support the general believe that the TNF/SIP pathway
is always responsible for S1P production and cell recruitment
during inflammation. This notion issued from the demonstra-
tion that TNF induces the up-regulation of Sphk1 expression
in certain cell lines in vitro. We could not confirm the role of
this pathway in lymphocyte trapping, since blockage of TNF
activity by Abs did not modify S1P recovery in LN injected
with inflammatory effectors (not shown). A detailed comparison
between the effects of TNF versus antigen injection on lym-
phocyte migration also reported that TNF does not recapitulate
the effects of antigen (13). The complexity of sphingolipids role
and the regulatory mechanisms governing their metabolism is
yet being revealed, but these studies are yet seriously handi-
capped by the low sensitivity of the methods for sphingolipids
detection.
We were surprised that CD4 T cells reportedly producing MIP-
1 chemokines to recruit CD8 T cells to provide help (36) had no
equivalent functions. It is possible that the relative roles of CD4
and CD8 T cells in recruitment depend of the immunization con-
text. MIP-1+ CD4 T cells were detected after immunization with
peptide and complete Freund’s adjuvant, whereas we here stud-
ied CD8-dependent responses. Moreover, it should be noted that
MIP-1 chemokines only attract previously activated T cells (37)
and thus are unlikely to be involved in the recruitment of naïve
cells during trapping.
Our results also modify perspectives on the putative relation-
ships between inflammation and immune responses. Inflamma-
tion is generally regarded as starting with an innate immune
response that is mediated by tissue-resident cells (38, 39) and
may eventually be perpetuated and amplified by certain T cell
types (such as TH17 cells). However, Th17 cells cannot initiate
inflammatory reactions since their generation requires a previ-
ously inflammatory milieu (40). We did not fully block innate
signaling in LM infection, since this signaling is complex and
involves multiple mediators [reviewed in Ref. (41)]. However, the
elimination of the MyD88 pathway reported to be the most impor-
tant in LM infection (42) did not modify the pro-inflammatory
burst. The strong inflammatory bursts of CD8 T cells after ster-
ile immunizations with male, sheep red blood or allogeneic cells
indicate that CD8 cognate interactions are also able to initiate
inflammatory reactions. This feature may have an important role
in a number of “sterile” responses to tissue antigens (such as in
transplantation) or in responses to self-antigens or tumor anti-
gens. Thus, while inflammation modulates cognate responses,
CD8 cognate responses may also initiate local inflammatory
reactions.
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